Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia pneumoniae and atherosclerosis.

Lee Ann Campbell1, Cho-Chou Kuo

  • 1Department of Pathobiology, University of Washington, Seattle 98195, USA. lacamp@u.washington.edu

Seminars in Respiratory Infections
|March 26, 2003
PubMed
Summary

Chlamydia pneumoniae, a respiratory pathogen, is linked to cardiovascular disease. This review examines evidence from in vitro, animal, and human studies to determine its role in atherogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of gene sequences as type for naming prokaryotes: Recommendations of the international committee on the taxonomy of chlamydiae.

New microbes and new infections·2023
Same author

Rectal Chlamydia trachomatis Infection: A Narrative Review of the State of the Science and Research Priorities.

Sexually transmitted diseases·2021
Same author

High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2020
Same author

<i>Punica granatum</i> L. Leaf Extract Attenuates Lung Inflammation in Mice with Acute Lung Injury.

Journal of immunology research·2018
Same author

Effects of Murine Norovirus on Chlamydia pneumoniae-Accelerated Atherosclerosis in ApoE(-/-) Mice.

Comparative medicine·2016
Same author

Atherosclerosis. Preface.

Archives of medical research·2015

Area of Science:

  • Microbiology
  • Cardiovascular Science
  • Infectious Disease

Background:

  • Chlamydia pneumoniae is a known human respiratory pathogen.
  • Epidemiological and direct detection studies suggest an association between C. pneumoniae and cardiovascular disease, including atherosclerosis.
  • The etiological role of C. pneumoniae in atherogenesis remains a critical research question.

Purpose of the Study:

  • To review and synthesize evidence from in vitro studies, animal models, and human intervention trials.
  • To evaluate the mechanistic role of Chlamydia pneumoniae in the development of atherosclerosis.
  • To address the question of whether C. pneumoniae contributes to the pathogenesis of cardiovascular disease.

Main Methods:

  • Summary of in vitro experimental findings.
  • Analysis of results from animal models of C. pneumoniae infection and induced atherogenesis.
  • Review of human intervention studies investigating the impact of C. pneumoniae.

Main Results:

  • In vitro studies provide evidence of C. pneumoniae's potential to induce inflammatory and cellular changes relevant to atherogenesis.
  • Animal models demonstrate that C. pneumoniae infection can promote the development and progression of atherosclerotic lesions.
  • Human intervention studies offer some support for a mechanistic role, though results are not entirely conclusive.

Conclusions:

  • Evidence from multiple study types suggests Chlamydia pneumoniae may play a role in the development of atherosclerosis.
  • Further research is needed to definitively establish the causal link and elucidate the precise mechanisms.
  • Understanding the role of C. pneumoniae in cardiovascular disease could lead to new therapeutic strategies.

Related Experiment Videos